Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Palisade Bio (PALI) Return on Capital Employed (2016 - 2025)

Palisade Bio (PALI) has disclosed Return on Capital Employed for 15 consecutive years, with 3.43% as the latest value for Q3 2025.

  • On a quarterly basis, Return on Capital Employed fell 169.0% to 3.43% in Q3 2025 year-over-year; TTM through Sep 2025 was 3.43%, a 169.0% decrease, with the full-year FY2024 number at 1.61%, down 55.0% from a year prior.
  • Return on Capital Employed was 3.43% for Q3 2025 at Palisade Bio, up from 3.51% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.92% in Q3 2023 to a low of 3.51% in Q2 2025.
  • A 5-year average of 1.73% and a median of 1.56% in 2022 define the central range for Return on Capital Employed.
  • Peak YoY movement for Return on Capital Employed: surged 143bps in 2023, then tumbled -201bps in 2025.
  • Palisade Bio's Return on Capital Employed stood at 1.87% in 2021, then skyrocketed by 35bps to 1.21% in 2022, then grew by 17bps to 1.01% in 2023, then plummeted by -115bps to 2.16% in 2024, then plummeted by -59bps to 3.43% in 2025.
  • Per Business Quant, the three most recent readings for PALI's Return on Capital Employed are 3.43% (Q3 2025), 3.51% (Q2 2025), and 2.0% (Q1 2025).